Dr Daniel Aguirre Mollehuanca

• Specialist in neurosurgery at the Jiménez Díaz Foundation University Hospital (2014- Present)
• Specialist in Neurosurgery at Hospital Universitario Rey Juan Carlos (2014- Present)
• Specialist in Neurosurgery at Hospital Universitario Infanta Elena (2014- Present)
• Specialist in Neurosurgery at Villalba General Hospital (2014- Present)
• MIR Neurosurgery at the Jiménez Díaz Foundation University Hospital (2009- 2014)

• Neuro-oncology
• Pediatric Neurosurgery
• Neuro Endoscopy and Skull Base Endoscopy
• Spine Surgery
• Familial neuro-oncological diseases

Research:

Familial neuro-oncological diseases:

• Von Hippel Lindau disease
• Neurofibromatosis
• Tuberous Sclerosis

Teaching:

• Teaching collaborator at the Autonomous University of Madrid (UAM). Faculty of Medicine (2009-Present)
• Teaching collaborator at the Rey Juan Carlos University of Móstoles. Faculty of Medicine (2015-Present)
• Teaching collaborator at the Autonomous University of Madrid (UAM). HU Jiménez Diaz Foundation School of Nursing (2014-Present)

- Cabrera-Montes J, Aguirre DT, Viñas-López J, Lorente-Herraiz L, Recio-Poveda L, Albiñana V, Pérez-Pérez J, Botella LM, Cuesta AM. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth. Acta Neurochir (Wien). 2023 Dec;165(12):4241-4251. doi: 10.1007/s00701-023-05825-x. Epub 2023 Oct 16.
- Barbero-Aznarez P, Perez-Tanoira R, Aguirre-Mollehuanca D, Trascasa-Caño A, Fortes-Alen J, Manzarbeitia-Arrambari F, Castillo-Alvarez J, Montoya-Bordon J, Petkova-Saiz E, Prieto-Perez L. Isolated central nervous system Whipple disease. Surg Neurol Int. 2022;13:477. doi: 10.25259/SNI_591_2022. eCollection 2022. Review.
- Albiñana V, Gallardo-Vara E, de Rojas-P I, Recio-Poveda L, Aguado T, Canto-Cano A, Aguirre DT, Serra MM, González-Peramato P, Martínez-Piñeiro L, Cuesta AM, Botella LM. Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel-Lindau Disease. J Clin Med. 2020 Aug 25;9(9). doi: 10.3390/jcm9092740.
- Cuesta AM, Albiñana V, Gallardo-Vara E, Recio-Poveda L, de Rojas-P I, de Las Heras KVG, Aguirre DT, Botella LM. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease. Sci Rep. 2019 Jul 11;9(1):10062. doi: 10.1038/s41598-019-46448-6.
- González-Rodríguez B, Villar Gómez de Las Heras K, Aguirre DT, Rodríguez-Padial L, Albiñana V, Recio-Poveda L, Cuesta AM, Botella LM, Jiménez-Escribano RM. Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial. BMJ Open Ophthalmol. 2019;4(1):e000203. doi: 10.1136/bmjophth-2018-000203. eCollection 2019.
- Cinalli G, Aguirre DT, Mirone G, Ruggiero C, Cascone D, Quaglietta L, Aliberti F, Santi SD, Buonocore MC, Nastro A, Spennato P. Surgical treatment of thalamic tumors in children. J Neurosurg Pediatr. 2018 Mar;21(3):247-257. doi: 10.3171/2017.7.PEDS16463. Epub 2017 Dec 22.
- Novello M, Di Rocco C, Tamburrini G, Frassanito P, Aguirre DT, Rosenberg AE, Coli A. Recurrent adult-type fibrosarcoma of the frontal bone in a child. Childs Nerv Syst. 2016 Jun;32(6):1169-73. doi: 10.1007/s00381-015-2998-6. Epub 2016 Jan 7.
- Lo Presti A, Aguirre DT, De Andrés P, Daoud L, Fortes J, Muñiz J. Cerebral sparganosis: case report and review of the European cases. Acta Neurochir (Wien). 2015 Sep;157(8):1339-43; discussion 1343. doi: 10.1007/s00701-015-2466-9. Epub 2015 Jun 18. Review.
Eimil-Ortiz M, Aguirre-Mollehuanca D, Sierra-Limpo A, Fontán-Tirado C, Villar-Villar ME. [Meropenem and valproic acid: a dangerous combination]. Rev Neurol. 2008 Jan 16-31;46(2):124-5